Clinical trial
CT Evaluated Sarcopenia Independently Predicts the Overal Survival After Transcatheter Aortic Valve Implantation
NCT05672160 is registered in ClinicalTrials.gov with Nemocnice AGEL Trinec-Podlesi a.s. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CT Evaluated Sarcopenia Independently Predicts the Overal Survival After Transcatheter Aortic Valve Implantation
- Lead sponsor
- Nemocnice AGEL Trinec-Podlesi a.s.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2022
- Completion date
- January 2, 2023
- Enrollment
- 930 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.